HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation.

Abstract
Infectious diseases can be cofactors in idiopathic interstitial pneumonias (IIP) pathogenesis; recent data suggests that toll-like receptors 9 (TLR9) ligands contribute to experimental chronic tissue remodeling. Real-time TAQMAN and immunohistochemical analysis of IIP normal surgical lung biopsies (SLBs), primary fibroblast lines grown from both IIP and normal SLBs indicate that TLR9 is prominently and differentially expressed in a disease-specific manner. TLR9 expression was increased in biopsies from patients with IIP compared with normal lung biopsies and its expression is localized to areas of marked interstitial fibrosis. TLR9 in fibroblasts appeared to be increased by profibrotic Th2 cytokines (IL-4 and IL-13) and this was true in fibroblasts cultured from the most severe form of IIP, idiopathic pulmonary fibrosis (IPF) SLBs, in non-specific interstitial pneumonia fibroblast lines, and in normal fibroblasts. Finally, confocal microscopy studies have shown that TLR9 activation by its synthetic agonist CpG-ODN significantly increased the expression of alpha smooth muscle actin, the main marker of myofibroblast differentiation. These data indicate that TLR9 expression may drive the abnormal tissue healing response in severe forms of IIP and its activation can have a key role in myofibroblast differentiation promoting the progression of disease during the terminal phase of IPF.
AuthorsA Meneghin, E S Choi, H L Evanoff, S L Kunkel, F J Martinez, K R Flaherty, G B Toews, C M Hogaboam
JournalHistochemistry and cell biology (Histochem Cell Biol) Vol. 130 Issue 5 Pg. 979-92 (Nov 2008) ISSN: 0948-6143 [Print] Germany
PMID18633634 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Actins
  • CPG-oligonucleotide
  • Interleukin-13
  • Oligodeoxyribonucleotides
  • RNA, Messenger
  • Recombinant Proteins
  • TLR9 protein, human
  • Toll-Like Receptor 9
  • Interleukin-4
Topics
  • Actins (metabolism)
  • Cell Differentiation (drug effects)
  • Cells, Cultured
  • Fibroblasts (drug effects, immunology, pathology)
  • Humans
  • Idiopathic Interstitial Pneumonias (genetics, immunology, pathology)
  • Idiopathic Pulmonary Fibrosis (genetics, immunology, pathology)
  • Immunohistochemistry
  • Interleukin-13 (metabolism)
  • Interleukin-4 (metabolism)
  • Lung (drug effects, immunology, pathology)
  • Microscopy, Confocal
  • Oligodeoxyribonucleotides (pharmacology)
  • Polymerase Chain Reaction
  • RNA, Messenger (metabolism)
  • Recombinant Proteins (metabolism)
  • Toll-Like Receptor 9 (agonists, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: